Methyl 2-(1,4-diazepan-1-yl)pyridine-4-carboxylate hydrochloride

Catalog No. :
ACLXBI656
CAS No. :
1235439-20-9
Molecular Formula :
C12H18ClN3O2
Molecular Weight :
271.75

IUPAC Name:methyl 2-(1,4-diazepan-1-yl)isonicotinate hydrochloride

Methyl 2-(1,4-diazepan-1-yl)pyridine-4-carboxylate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$195.00Login to see priceInquiryInquiry
100mg95%$281.00Login to see priceInquiryInquiry
250mg95%$394.00Login to see priceInquiryInquiry
1g95%$804.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-(1,4-diazepan-1-yl)pyridine-4-carboxylate hydrochloride
IUPAC Namemethyl 2-(1,4-diazepan-1-yl)isonicotinate hydrochloride
MDL No.MFCD16040153
Molecular FormulaC12H18ClN3O2
Molecular Weight271.75
SMILESO=C(C1=CC(N2CCNCCC2)=NC=C1)OC.[H]Cl
InChI KeyBSROCTMOVKNUFL-UHFFFAOYSA-N
Synonym4-Pyridinecarboxylic acid, 2-(hexahydro-1H-1,4-diazepin-1-yl)-, methyl ester, hydrochloride (1:1);Methyl 2-(1,4-Diazepan-1-yl)pyridine-4-carboxylate Hydrochloride
CAS No.1235439-20-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLXBI656 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWICD431 route compound structure diagram
    ACWICD43158481-11-1 In Stock
  4. Then
  5. ACLXBI656 route product structure diagram
    ACLXBI6561235439-20-9
Inquiry

2. ACLXBI656 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLXBI656 route product structure diagram
    ACLXBI6561235439-20-9
Inquiry

Comments (0)